Beam Therapeutics Inc.
BEAM
$25.17
-$0.15-0.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 316.71% | -10.20% | 6.39% | -20.94% | 6.53% |
| Total Depreciation and Amortization | 1.94% | 0.40% | 0.18% | 1.56% | -0.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -805.19% | 94.59% | -33.43% | -13.54% | 2.21% |
| Change in Net Operating Assets | -1,329.81% | -307.09% | 113.51% | -22.74% | 18.93% |
| Cash from Operations | -2.22% | -6.58% | 26.41% | -36.04% | 13.34% |
| Capital Expenditure | 25.48% | -59.79% | -2.32% | -3.20% | -88.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.52% | 142.29% | -37.08% | -194.41% | 391.91% |
| Cash from Investing | 65.12% | 138.53% | -36.23% | -199.06% | 411.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 12.60% | 51.04% | -99.77% | 13,645.03% | 135.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.60% | 51.04% | -99.77% | 13,645.03% | 172.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 290.85% | 94.24% | -200.55% | 358.04% | 185.83% |